News
ALK (ALKB:DC / OMX: ALK B) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved EURneffy® 2 mg in the United Kingdom (UK) for anaphylaxis treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback